As of 2025-07-21, the Intrinsic Value of Enzon Pharmaceuticals Inc (ENZN) is 0.22 USD. This ENZN valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.09 USD, the upside of Enzon Pharmaceuticals Inc is 158.70%.
The range of the Intrinsic Value is 0.12 - 0.29 USD
Based on its market price of 0.09 USD and our intrinsic valuation, Enzon Pharmaceuticals Inc (ENZN) is undervalued by 158.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 0.12 - 0.29 | 0.22 | 158.7% |
| DCF (Growth 10y) | 0.23 - 0.04 | 0.15 | 80.3% |
| Fair Value | 0.26 - 0.26 | 0.26 | 208.35% |
| P/E | 0.04 - 0.05 | 0.04 | -48.4% |
| EPV | 0.43 - 0.37 | 0.40 | 371.4% |
| DDM - Stable | 0.08 - 0.20 | 0.14 | 62.7% |
| DDM - Multi | 0.18 - 0.29 | 0.22 | 154.8% |
| Market Cap (mil) | 6.31 |
| Beta | 0.23 |
| Outstanding shares (mil) | 74.21 |
| Enterprise Value (mil) | -40.55 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.44% |
| Cost of Debt | 5.00% |
| WACC | 5.87% |